Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients

Diabetologia

Volumn 49, Issue 7, 2006, Pages 1670-1676

  Katakami, N ^a   Kaneto, H ^a   Matsuhisa, M ^a   Miyatsuka, T ^a   Sakamoto, K ^a   Kawamori, D ^a   Yoshiuchi, K ^a   Nakamura, Y ^a   Kato, K ^a   Yamamoto, K ^a   Kosugi, K ^b   Hori, M ^a   Yamasaki, Y ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Carotid artery; CD40 ligand; IMT; Intima media thickness; Type 1 diabetes

Indexed keywords

CD40 LIGAND;

ADULT; AORTA ATHEROSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL EXAMINATION; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; SOLUBILITY; STATISTICAL SIGNIFICANCE;

ADULT; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CD40 LIGAND; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; JAPAN; MALE; TUNICA INTIMA;

EID: 33744935240     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0281-9     Document Type: Article

References (25)

1. Schonbeck U, Libby P (2001) CD40 signaling and plaque instability. Circ Res 89:1092-1103
2. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
3. Adams DH, Shaw S (1994) Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343:831-836
4. Lutgens E, Gorelik L, Daemen MJ, et al (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5:1313-1316
5. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394:200-203
6. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation of CD40L with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917-4925
7. Hollenbaugh D, Mischel-Petty N, Edwards CP, et al (1995) Expression of functional CD40L by vascular endothelial cells. J Exp Med 182:33-40
8. Aukrust P, Muller F, Ueland T, et al (1999) Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614-620
9. Garlichs CD, Eskafi S, Raaz D, et al (2001) Patients with acute coronary syndrome express enhanced CD40 ligand/CD154 on platelets. Heart 86:649-655
10. Tsakiris DA, Tschopl M, Wolf F, Labs KH, Jager KA, Marbet GA (2000) Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease. Blood Coagul Fibrinolysis 11:165-173
11. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266-2268
12. Heeschen C, Dimmeler S, Hamm CW, et al (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111
13. Varo N, Vincent D, Libby P, et al (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients. Circulation 107:2664-2669
14. Harding SA, Sommerfield AJ, Sarma J, et al (2004) Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176:321-325
15. Yamasaki Y, Kawamori R, Matsushima H, et al (1994) Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43:634-639
16. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
17. Kawamori R, Yamasaki Y, Matsushima H, et al (1992) Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15:1290-1294
18. Yamasaki Y, Kodama M, Nishizawa H, et al (2000) Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23:1310-1315
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R (1986) Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399-1406
20. Cipollone F, Chiarelli F, Davi G, et al (2005) Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48:1216-1224
21. Targher G, Zoppini G (2004) Soluble CD40L in young type 1 diabetic individuals without clinical microvascular and macrovascular complications. Diabetes Care 27:1236-1237
22. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardio-vascular disease. Circulation 106:896-899
23. O'Leary DH, Polak JF, Kronmal RA, et al (1992) Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 23:1752-1760
24. Noelle RJ (1996) CD40 and its ligand in host defense. Immunity 4: 415-419
25. Mach F, Schönbeck U, Bonnefoy J-Y, Pober JS, Libby P (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396-399